987 results on '"Salvetti, Marco"'
Search Results
2. Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study
3. Co-existence of Myelin Oligodendrocyte Glycoprotien Antibody-associated Disease (MOGAD) and Spinocerebellar Ataxia type 1 (SCA1): A case report
4. Long-Term Follow-Up before and during Riluzole Treatment in Six Patients from Two Families with Spinocerebellar Ataxia Type 7
5. Cerebral hemodynamics and cognitive functions in the acute and subacute stage of mild ischemic stroke: a longitudinal pilot study
6. Correction: Long-Term Follow-Up Before and During Riluzole Treatment in Six Patients from Two Families with Spinocerebellar Ataxia Type 7
7. Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors
8. Signs and symptoms of COVID‐19 in patients with multiple sclerosis
9. Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients
10. Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study
11. The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis
12. Multiple Sclerosis
13. Riluzole in Progressive Cerebellar Ataxias
14. Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
15. Distal upper limb involvement in myasthenia-myositis association
16. Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies
17. SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets
18. Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy
19. The impact of cerebral vasomotor reactivity on cerebrovascular diseases and cognitive impairment
20. Exploring miRNAs’ Based Modeling Approach for Predicting PIRA in Multiple Sclerosis: A Comprehensive Analysis
21. Different Susceptibility of T and B Cells to Cladribine Depends On Their Levels of Deoxycytidine Kinase Activity Linked to Activation Status
22. The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study
23. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
24. High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP
25. Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome
26. Nerve high-resolution ultrasound in a 2-year follow-up of radial nerve palsy related to humeral shaft fractures.
27. Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation
28. Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World Experience
29. Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study
30. EBV infection drives MS pathology: Yes
31. Case report: A novel mutation of glial fibrillary acidic protein gene causing juvenile-onset Alexander disease
32. Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up
33. The tolerability, safety and efficacy of safinamide in elderly Parkinson’s disease patients: a retrospective study
34. Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis
35. Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience
36. Facing the urgency of therapies for progressive MS — a Progressive MS Alliance proposal
37. Gut Microbiota Composition Is Causally Linked to Multiple Sclerosis: A Mendelian Randomization Analysis.
38. Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy.
39. Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms
40. Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study
41. Safinamide improves executive functions in fluctuating Parkinson’s disease patients: an exploratory study
42. Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing–remitting multiple sclerosis patients
43. Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy
44. A single-agent extension of the SIR model describes the impact of mobility restrictions on the COVID-19 epidemic
45. An “all-wheel drive” proposal to accelerate clinical research in common and rare neurological diseases
46. Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study
47. Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants
48. Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study
49. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context
50. Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.